Breaking News Instant updates and real-time market news.

AIMT

Aimmune

$35.80

0.48 (1.36%)

07:43
02/07/18
02/07
07:43
02/07/18
07:43

Cantor optimistic going into Aimmune Phase III peanut allergy study

Cantor Fitzgerald analyst William Tanner is optimistic on the success of Aimmune Therapeutics' Phase data from the pivotal Palisade clinical trial of AR101, anticipated to occur in February. The company is well positioned to provide the first FDA-approved treatment for peanut hypersensitivity, the most-prevalent food allergy, Tanner tells investors in a research note. He believes Aimmune shares could command up to $84 in a "post-Palisade data acquisition scenario," or up to $93 under certain market scenarios. The analyst keeps an Overweight rating on Aimmune with a $55 price target.

AIMT Aimmune
$35.80

0.48 (1.36%)

12/20/17
BARD
12/20/17
INITIATION
Target $64
BARD
Outperform
Aimmune initiated with an Outperform at Baird
Baird initiated Aimmune with Outperform and $64 price target saying the company stands to benefit in the peanut allergy space following DBV's recent failure. The analyst recommends buying shares ahead of AR101 Phase 3 peanut allergy data headlined by PALISADE in Q1 saying it stands to gain more share should it surpass the FDA's 15% efficacy margin.
01/16/18
CANT
01/16/18
NO CHANGE
Target $55
CANT
Overweight
Aimmune Q1 data should be adequate for approval, says Cantor Fitzgerald
Cantor Fitzgerald analyst William Tanner "strongly" believes Aimmune Therapeutics' Palisade Phase 3 trial data in Q1 will be adequate for FDA approval. AR101 could be an important therapy for treating peanut allergy, Tanner tells investors in a research note following a recent meeting with management. The analyst keeps an Overweight rating on Aimmune shares with a $55 price target.
01/31/18
ROTH
01/31/18
NO CHANGE
Target $75
ROTH
Buy
Aimmune price target raised to $75 from $60 at Roth Capital
Roth Capital analyst Jotin Marango raised his price target for Aimmune to $75 from $60 as he is now more bullish on its value ahead of PALISADE study topline in the next few weeks, full study data on March 4 at AAAAI in Orlando, and potential M&A theses or scenarios that a study win is likely to generate and support. The analyst reiterates a Buy rating on the shares.
02/07/18
RBCM
02/07/18
INITIATION
Target $55
RBCM
Outperform
Aimmune initiated with an Outperform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Aimmune with an Outperform rating and a price target of $55. MacKay contends that the company's "phase 3 PALISADE study should succeed based on AR101's phase 2 experience, phase 3 patient characteristics, and comparative trials within the peanut allergy field". He sees AR101 potentially growing the peanut allergy desensitization market, reaching about $1.9B in peak unadjusted global sales.

TODAY'S FREE FLY STORIES

BX

Blackstone

$32.72

-0.31 (-0.94%)

, GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

17:56
06/19/18
06/19
17:56
06/19/18
17:56
Hot Stocks
Blackstone to acquire PSAV »

PSAV announced that it…

BX

Blackstone

$32.72

-0.31 (-0.94%)

GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:42
06/19/18
06/19
17:42
06/19/18
17:42
Recommendations
Starbucks analyst commentary  »

Starbucks has no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:36
06/19/18
06/19
17:36
06/19/18
17:36
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle reverses, now down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Earnings
Oracle sees Q1 adjusted EPS 67c-69c in USD, consensus 72c »

Sees Q1 adjusted EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Hot Stocks
Walgreens Boots Alliance to replace General Electric in DJIA »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BA

Boeing

$341.10

-13.69 (-3.86%)

, FDX

FedEx

$258.35

-5.295 (-2.01%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Hot Stocks
Boeing announces FedEx order valued at $6.6B for 24 medium and large freighters »

Boeing (BA) and FedEx…

BA

Boeing

$341.10

-13.69 (-3.86%)

FDX

FedEx

$258.35

-5.295 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Sep

  • 21

    Sep

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

17:31
06/19/18
06/19
17:31
06/19/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Walgreens Boots Alliance »

Walgreens jumps 4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:29
06/19/18
06/19
17:29
06/19/18
17:29
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Catz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

GE

General Electric

$12.96

-0.24 (-1.82%)

17:26
06/19/18
06/19
17:26
06/19/18
17:26
Hot Stocks
Breaking Hot Stocks news story on General Electric »

GE drops 21c to $12.74…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPOP

Popular

$46.64

0.19 (0.41%)

17:26
06/19/18
06/19
17:26
06/19/18
17:26
Syndicate
Breaking Syndicate news story on Popular »

Popular files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRAX

Social Reality

$4.66

0.2 (4.48%)

17:25
06/19/18
06/19
17:25
06/19/18
17:25
Syndicate
Breaking Syndicate news story on Social Reality »

Social Reality files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:25
06/19/18
06/19
17:25
06/19/18
17:25
Conference/Events
Stephens restaurants analyst to hold a dinner meeting »

Restaurant Analyst…

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says June comp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Earnings
Breaking Earnings news story on Oracle »

Oracle sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

VALE

Vale

$12.97

-0.21 (-1.59%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Syndicate
Breaking Syndicate news story on Vale »

Vale files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

17:21
06/19/18
06/19
17:21
06/19/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Walgreens Boots Alliance, General Electric »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

RMTI

Rockwell Medical

$5.47

0.07 (1.30%)

17:20
06/19/18
06/19
17:20
06/19/18
17:20
Hot Stocks
Rockwell Medical parties to engage in mediation June 19 »

On June 13, the Circuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:18
06/19/18
06/19
17:18
06/19/18
17:18
Hot Stocks
Oracle sees FY19 CapEx 'similar' to FY18 »

Sees FY19 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:16
06/19/18
06/19
17:16
06/19/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees some EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:16
06/19/18
06/19
17:16
06/19/18
17:16
Earnings
Starbucks cuts FY18 adjusted EPS view to $2.39-$2.43 from $2.48-$2.53 

Consensus $2.49.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

VALE

Vale

$12.97

-0.21 (-1.59%)

17:15
06/19/18
06/19
17:15
06/19/18
17:15
Hot Stocks
Vale exposed to about 40% of future cobalt production from Voisey's Bay »

On June 11 , Vale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:14
06/19/18
06/19
17:14
06/19/18
17:14
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says May 29…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

FDX

FedEx

$258.35

-5.295 (-2.01%)

17:13
06/19/18
06/19
17:13
06/19/18
17:13
Hot Stocks
FedEx sees new pension accounting rules reducing operating margins by 90bps »

Expects much lower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Sep

  • 21

    Sep

CCNI

Command Center, Inc

$5.45

-0.1 (-1.80%)

17:11
06/19/18
06/19
17:11
06/19/18
17:11
Hot Stocks
Breaking Hot Stocks news story on Command Center, Inc »

Ephraim G. Fields reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:09
06/19/18
06/19
17:09
06/19/18
17:09
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Catz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.